By Scott Flaherty ( February 7, 2013, 6:30 PM EST) -- The Federal Circuit ruled Thursday that a Merck & Co. Inc. unit can enforce a patent for an active ingredient in the cholesterol drugs Vytorin and Zetia, snuffing out generic-drug maker Mylan Inc.'s challenge to the patent's validity....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.